Arrowstreet Capital
NUVB icon

Arrowstreet Capital’s Nuvation Bio NUVB Stock Holding History

Arrowstreet Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.21M Buy
1,621,686
+182,329
+13% +$891K ﹤0.01% 1101
2026
Q1 		$6.17M Buy
1,439,357
+619,725
+76% +$3.45M ﹤0.01% 1098
2025
Q4 		$7.34M Buy
819,632
+355,636
+77% +$2.2M ﹤0.01% 1027
2025
Q3 		$1.72M Buy
+463,996
New +$1.26M ﹤0.01% 1477
2024
Q2 		– Sell
-38,254
Closed -$139K – 1699
2024
Q1 		$139K Buy
+38,254
New +$73.5K ﹤0.01% 1600

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital's NUVB Position: Q2 2026 in Review

Arrowstreet Capital increased its Nuvation Bio (NUVB) stake by 13% in Q2 2026, buying an estimated $891K and bringing the position to 1,621,686 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Arrowstreet Capital first reported a position in NUVB in Q1 2024 and has held it in 5 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Arrowstreet Capital held 1,621,686 shares of Nuvation Bio worth $9.21M as of Q2 2026.
  • Arrowstreet Capital bought 182,329 Nuvation Bio shares in Q2 2026, an estimated $891K.
  • Nuvation Bio made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1101 holding.
  • Arrowstreet Capital first reported a position in Nuvation Bio in Q1 2024 and has held it in 5 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.